Vycor Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VYCO research report →
Price Chart
About the company
Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units.
- CEO
- Peter C. Zachariou
- IPO
- 2013
- Employees
- 7
- HQ
- Boca Raton, FL, US
Get TickerSpark's AI analysis on VYCO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.24M
- P/E
- -37.22
- PEG
- 0.04
- P/S
- 1.24
- P/B
- -0.53
- EV/EBITDA
- 31.64
- Div Yield
- 0.00%
- Gross Margin
- 82.60%
- Op Margin
- 2.67%
- Net Margin
- -3.32%
- ROE
- 1.44%
- ROIC
- -1.46%
Latest fiscal year · YoY change
- Revenue
- $1.86M+17.2%
- Gross Profit
- $1.50M+5.6%
- Op Income
- $33.90K
- Net Income
- $-72,426+32.4%
- EPS
- $-0.01-260.6%
- OCF Growth
- -122.4%
- FCF Growth
- -133.4%
- 52W High
- $0.20
- 52W Low
- $0.03
- 50D MA
- $0.07
- 200D MA
- $0.08
- Beta
- -0.53
- RSI (14)
- 52
- Avg Volume
- 6.14K
No earnings-call transcripts are available for VYCO yet.
- Free Float
- 38.9%
- Shares Outstanding
- 33.37M
- Float Shares
- 12.98M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 30, 22 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Jun 30, 22 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Mar 31, 22 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Sep 30, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Sep 30, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Jun 30, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Mar 31, 21 | Rush Lowell | other | 33,333 |
| Mar 31, 21 | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | other | 535,714 |
| Apr 1, 21 | GIRGENTI STEVEN | other | 33.333 |
| Jan 1, 21 | GIRGENTI STEVEN | other | 33.333 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VYCO coverage
Recent articles, reports, and earnings notes.
No research on VYCO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VYCO report →